Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer®-Accredited Facilities in the United States Article

cited authors

  • Sitler, Collin A.; Tian, Chunqiao; Hamilton, Chad A.; Richardson, Michael T.; Chan, John K.; Kapp, Daniel S.; Leath III, Charles A.; Casablanca, Yovanni; Washington, Christina; Chappell, Nicole P.; Klopp, Ann H.; Shriver, Craig D.; Tarney, Christopher M.; Bateman, Nicholas W.; Conrads, Thomas P.; Maxwell, George Larry; Phippen, Neil T.; Darcy, Kathleen M.

authors

Publication Date

  • March 1, 2024

webpage

published in

category

keywords

  • cervical cancer
  • chemotherapy
  • external beam radiation
  • first-line treatment
  • immunotherapy
  • intracavitary brachytherapy
  • radiation
  • stage IVB
  • survival
  • targeted therapy

volume

  • 16

issue

  • 5